FDA approves first once-monthly buprenorphine injection, a medication-assisted treatment option for opioid use disorder

SILVER SPRING, Md., Nov. 30, 2017 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated...